首页> 外文期刊>Protein Expression and Purification >Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
【24h】

Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.

机译:通过用酵母泛素C末端水解酶和人免疫缺陷病毒蛋白酶消化重组泛素CTAPIII来产生趋化因子CTAPIII和NAP / 2。

获取原文
获取原文并翻译 | 示例
           

摘要

Recombinant yeast ubiquitin C-terminal hydrolase (YUH1), which has an N-terminal (His)(6) tag, and an autolysis-resistant mutant of the human immunodeficiency virus-1 protease (HIV-1 Pr) have been used as specific proteases to yield peptides from a ubiquitin conjugate. In the present example, connective tissue-activating peptide (CTAPIII) and neutrophil-activating peptide 2 (NAP/2) were generated by digestion of a ubiquitin-CTAPIII conjugate with YUH1 and HIV Pr, respectively, as indicated below: [see text] YUH1 cleaved at the peptide bond formed by the C-terminal Gly(76) of ubiquitin (Ub) and the N-terminal Asn(1) of the 85-residue peptide CTAPIII. The HIV-1 Pr cleaved between Tyr(15) and Ala(16), the N-terminal Ala of the 70-residue peptide NAP/2. Both enzymes produced authentic peptides from the Ub fusion protein, with a nearly 100% yield. The liberated CTAPIII and NAP/2 were separated from (His)(6)-Ub, the trace amounts of unreacted (His)(6)-Ub-CTAPIII, HIV-1 Pr, and the (His)(6)-YUH1 by passage over a nickel-chelate column; the final yield was about 10 mg of peptide/liter of cell culture. (His)(6)-YUH1, the HIV Pr mutant, and the (His)(6)-Ub-CTAPIII substrate were all expressed individually in Escherichia coli. (His)(6)-YUH1 and (His)(6)-Ub-CTAPIII were highly expressed in a soluble form, but about 75% of the total (His)(6)-YUH1 was also found in inclusion bodies. Both proteins from the soluble fractions were easily purified in a single step by immobilized metal ion affinity chromatography with a yield of about 27 mg of (His)(6)-Ub-CTAPIII and 13.6 mg of (His)(6)-YUH1 protein/liter of cell culture. Chemotactic factor activity, as assessed by the neutrophil shape change assay, was observed for NAP/2, but not for CTAPIII. This strategy, which employs YUH1 and the HIV-1 Pr as tools for the highly selective cleavage of the chimeric substrate, should be applicable to the large-scale production of a variety of peptides. Copyright 1999 Academic Press.
机译:具有N末端(His)(6)标签的重组酵母泛素C末端水解酶(YUH1)和人免疫缺陷病毒1蛋白酶(HIV-1 Pr)的自溶抗性突变体已被用作特异性蛋白酶从泛素结合物中产生肽。在本实例中,结缔组织激活肽(CTAPIII)和嗜中性白细胞激活肽2(NAP / 2)通过分别用YUH1和HIV Pr消化遍在蛋白-CTAPIII缀合物而产生,如下所示: YUH1在由泛素(Ub)的C端Gly(76)和85个残基的肽CTAPIII的N端Asn(1)形成的肽键处裂解。 HIV-1 Pr在Tyr(15)和Ala(16)(70个残基的肽NAP / 2的N末端Ala)之间切割。两种酶均由Ub融合蛋白产生了真实的肽,收率接近100%。将游离的CTAPIII和NAP / 2与(His)(6)-Ub,痕量未反应的(His)(6)-Ub-CTAPIII,HIV-1 Pr和(His)(6)-YUH1分离通过镍螯合物柱;最终产量为每升细胞培养液约10 mg肽。 (His)(6)-YUH1,HIV Pr突变体和(His)(6)-Ub-CTAPIII底物均在大肠杆菌中单独表达。 (His)(6)-YUH1和(His)(6)-Ub-CTAPIII以可溶形式高表达,但在包涵体中也发现了全部(His)(6)-YUH1的约75%。可溶级分中的两种蛋白质都可以通过固定的金属离子亲和色谱法轻松地一步纯化,产量约为27 mg(His)(6)-Ub-CTAPIII和13.6 mg(His)(6)-YUH1蛋白/升细胞培养。对于NAP / 2,未观察到通过嗜中性粒细胞形状变化测定法评估的趋化因子活性,但对于CTAPIII,未观察到。该策略采用YUH1和HIV-1 Pr作为嵌合底物的高选择性裂解工具,应适用于大规模生产各种肽。版权所有1999 Academic Press。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号